These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29720540)

  • 1. Porcupine inhibitors impair trabecular and cortical bone mass and strength in mice.
    Funck-Brentano T; Nilsson KH; Brommage R; Henning P; Lerner UH; Koskela A; Tuukkanen J; Cohen-Solal M; Movérare-Skrtic S; Ohlsson C
    J Endocrinol; 2018 Jul; 238(1):13-23. PubMed ID: 29720540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway.
    Shah K; Panchal S; Patel B
    Pharmacol Res; 2021 May; 167():105532. PubMed ID: 33677106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
    Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
    J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porcupine inhibitor LGK‑974 inhibits Wnt/β‑catenin signaling and modifies tumor‑associated macrophages resulting in inhibition of the malignant behaviors of non‑small cell lung cancer cells.
    Tang Y; Jiang M; Chen A; Qu W; Han X; Zuo J; Xu G; Song Y; Chen C; Ke X
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma.
    Li J; Wu G; Xu Y; Li J; Ruan N; Chen Y; Zhang Q; Xia Q
    Biomed Res Int; 2020; 2020():2527643. PubMed ID: 32104684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
    Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ
    Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of the Porcupine Inhibitor WNT974 in Mice.
    Zhang LS; Lum L
    Methods Mol Biol; 2016; 1481():111-7. PubMed ID: 27590157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
    Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
    Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.
    Liu J; Pan S; Hsieh MH; Ng N; Sun F; Wang T; Kasibhatla S; Schuller AG; Li AG; Cheng D; Li J; Tompkins C; Pferdekamper A; Steffy A; Cheng J; Kowal C; Phung V; Guo G; Wang Y; Graham MP; Flynn S; Brenner JC; Li C; Villarroel MC; Schultz PG; Wu X; McNamara P; Sellers WR; Petruzzelli L; Boral AL; Seidel HM; McLaughlin ME; Che J; Carey TE; Vanasse G; Harris JL
    Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20224-9. PubMed ID: 24277854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in mice.
    Lloyd SA; Yuan YY; Kostenuik PJ; Ominsky MS; Lau AG; Morony S; Stolina M; Asuncion FJ; Bateman TA
    Calcif Tissue Int; 2008 May; 82(5):361-72. PubMed ID: 18465074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone density, strength, and formation in adult cathepsin K (-/-) mice.
    Pennypacker B; Shea M; Liu Q; Masarachia P; Saftig P; Rodan S; Rodan G; Kimmel D
    Bone; 2009 Feb; 44(2):199-207. PubMed ID: 18845279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody.
    Li X; Niu QT; Warmington KS; Asuncion FJ; Dwyer D; Grisanti M; Han CY; Stolina M; Eschenberg MJ; Kostenuik PJ; Simonet WS; Ominsky MS; Ke HZ
    Endocrinology; 2014 Dec; 155(12):4785-97. PubMed ID: 25259718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible
    Ohlsson C; Henning P; Nilsson KH; Wu J; Gustafsson KL; Sjögren K; Törnqvist A; Koskela A; Zhang FP; Lagerquist MK; Poutanen M; Tuukkanen J; Lerner UH; Movérare-Skrtic S
    J Endocrinol; 2018 May; 237(2):113-122. PubMed ID: 29530924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.
    Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Nakanishi Y; Tanaka M; Bruce M; Deacon S; Kawabata K
    Bone; 2016 May; 86():43-52. PubMed ID: 26921823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea supplementation benefits body composition and improves bone properties in obese female rats fed with high-fat diet and caloric restricted diet.
    Shen CL; Han J; Wang S; Chung E; Chyu MC; Cao JJ
    Nutr Res; 2015 Dec; 35(12):1095-105. PubMed ID: 26525915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
    Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
    Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors.
    Dong Y; Li K; Xu Z; Ma H; Zheng J; Hu Z; He S; Wu Y; Sun Z; Luo L; Li J; Zhang H; Zhang X
    Bioorg Med Chem; 2015 Nov; 23(21):6855-68. PubMed ID: 26455655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.